Initial Results of a Positron Tomograph for Prostate Imaging
暂无分享,去创建一个
J. Qi | W.W. Moses | J.S. Huber | S.E. Derenzo | T.F. Budinger | R.H. Huesman | D. Wilson | W.S. Choong | J. Hu | G.C. Wang | S. Oh
[1] T. Hara,et al. PET imaging of prostate cancer using carbon-11-choline. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] J. Kurhanewicz,et al. Improved prostate cancer imaging with SPECT/CT and MRI/MRSI , 2004, IEEE Transactions on Nuclear Science.
[3] R. Coleman,et al. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] T. Shiga,et al. Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[5] Mithat Gonen,et al. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] R. Coleman,et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. , 2001, Cancer research.
[7] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[8] N. Shinoura,et al. Brain tumors: detection with C-11 choline PET. , 1997, Radiology.
[9] T. Turkington,et al. PET prostate imaging with small planar detectors , 2004, IEEE Symposium Conference Record Nuclear Science 2004..
[10] T. Hara,et al. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] Ronald H. Huesman,et al. Conceptual design of a compact positron tomograph for prostate imaging , 2000 .
[12] W Vaalburg,et al. Imaging of bladder cancer using C-11 choline positron emission tomography (PET). , 2000 .
[13] J. Kurhanewicz,et al. Improved prostate cancer imaging with SPECT/CT and MRI/MRSI , 2005, IEEE Symposium Conference Record Nuclear Science 2004..
[14] Ludwig G Strauss,et al. PET imaging of prostate cancer with 11C-acetate. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] N. Shinoura,et al. PET imaging of brain tumor with [methyl-11C]choline. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] Sven N. Reske,et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma , 2000, European Journal of Nuclear Medicine.
[17] Nobuyuki Oyama,et al. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] Z. Lengyel,et al. Detection of prostate cancer with 11C-methionine positron emission tomography. , 2005, The Journal of urology.
[20] J Kurhanewicz,et al. The prostate: MR imaging and spectroscopy. Present and future. , 2000 .
[21] W. W. Moses,et al. List-mode maximum-likelihood reconstruction applied to positron emission mammography (PEM) with irregular sampling , 2000, IEEE Transactions on Medical Imaging.
[22] J. Humm,et al. Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate Cancer. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[23] S. Rosenthal,et al. Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation. , 1996, Clinical nuclear medicine.
[24] G. Llosá. First Results in the Development of a Compton Probe Prototype for Prostate Imaging , 2004 .
[25] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[26] J. Karstens,et al. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[27] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[28] N. Clinthorne,et al. Performance evaluation of Compton probe and SPECT in lesion detection , 2004, IEEE Symposium Conference Record Nuclear Science 2004..
[29] Magnus Dahlbom,et al. Factor analysis in prostate cancer: delineation of organ structures and automatic generation of in- and output functions , 2002 .